TNYA logo

TNYATenaya Therapeutics Inc

$0.6983
$0.0117
(1.65%)
Today
Closed $0.6983
$0.0017
(0.24%)
After Hours
Updated: 07:56 PM EDT
EarningsAug 12
Mkt Cap$154.07M
Vol2.06M
News
all
press releases
Tenaya Therapeutics, Inc. (TNYA) Reports Q1 Loss, Misses Revenue Estimates
Tenaya Therapeutics (TNYA) delivered earnings and revenue surprises of +4.26% and -97.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
More News
News Placeholder
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Rating of "Moderate Buy" by Analysts
Tenaya Therapeutics, Inc. (NASDAQ:TNYA - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven research firms that are covering the company, MarketBeat...
MarketBeat
News Placeholder
Tenaya Therapeutics (NASDAQ:TNYA) Shares Down 5% - Here's What Happened
Tenaya Therapeutics (NASDAQ:TNYA) Shares Down 5% - What's Next...
MarketBeat
News Placeholder
Tenaya Therapeutics (NASDAQ:TNYA) Rating Lowered to "Sell" at Wall Street Zen
Wall Street Zen cut shares of Tenaya Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat
News Placeholder
Chardan Capital Reiterates Buy Rating for Tenaya Therapeutics (NASDAQ:TNYA)
Chardan Capital reiterated a "buy" rating and set a $8.00 price target on shares of Tenaya Therapeutics in a research report on Thursday...
MarketBeat
News Placeholder
Tenaya Therapeutics (NASDAQ:TNYA) Issues Earnings Results, Meets Expectations
Tenaya Therapeutics (NASDAQ:TNYA - Get Free Report) released its earnings results on Wednesday. The company reported ($0.12) earnings per share for the quarter, hitting analysts' consensus estimates...
MarketBeat
News Placeholder
Lifesci Capital Upgrades Tenaya Therapeutics (NASDAQ:TNYA) to Strong-Buy
Lifesci Capital raised shares of Tenaya Therapeutics to a "strong-buy" rating in a report on Thursday...
MarketBeat
News Placeholder
TNYA Pulls Back After Hours Following Significant $1.13B Deal-Spurred Rally
Tenaya shares closed 40% higher in the regular trading session after it entered into a research collaboration deal with Alnylam Pharmaceuticals.
Stocktwits
News Placeholder
Tenaya Therapeutics Stock Jumps After New Alnylam Deal
Tenaya Therapeutics stock jumps after announcing a research collaboration with Alnylam worth up to $1.13 billion in milestone payments.read more...
Benzinga
News Placeholder
Tenaya Therapeutics (TNYA) Projected to Post Earnings on Monday
Tenaya Therapeutics (NASDAQ:TNYA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 9. (View Earnings Report at...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.